Delivery Order SPE2DB22D1103-SPE2DB25FTLR6

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,968.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Wegovy 2.4 mg/0.75 ml pen 0.75 ml, a medication used for the treatment of obesity. The contract is a firm fixed-price delivery order with a performance period that extends through May 5, 2025. Amerisourcebergen Drug Corp is not a small business, and the contract...
This federal contract award, valued at $2,203.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $2,866.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used in the treatment of obesity. The contract has a ceiling value of $3,842.83 and a completion date of December 19, 2023. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 1 mg/0.5 ml pens, a medication used to treat obesity. The contract has a ceiling value of $2,555.41 and a completion date of April 24, 2025. This award is not set-aside and is a firm fixed-price delivery order contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used to treat obesity. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $10,541.65 and a performance period through May 1, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp...
This federal contract award, valued at $7,935.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a prescription medication used for chronic weight management. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $1,224.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Wegovy 1.7 mg/0.75 ml pens, a medication used for chronic weight management. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $4,089.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract is a Firm Fixed Price Delivery Order that runs through February 28, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,504.68 firm-fixed-price delivery order is for the supply of Wegovy 2.4 mg/0.75 ml pens, a prescription medication used for chronic weight management. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTLR6
    Delivery Order

This federal contract award, valued at $2,333.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Wegovy 2.4 mg/0.75 ml pen 0.75 ml, a medication used for the treatment of obesity. The contract is a firm fixed-price delivery order with a performance period ending on May 2, 2025. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization that has held a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award is not set-aside and represents open competition for the required medical supplies.

Generated 7/31/25, 10:27 AM